San Diego Digestive Diseases Research Center
San Diego Digestive Diseases Research Center
批准号:
10395968
负责人:
LARS ECKMANN
金额:
$118.47万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2024-04-30
关键词:
Animal ModelAreaBasic ScienceBiomedical ResearchCaliforniaCell Culture TechniquesClinicalClinical InvestigatorClinical ResearchCollaborationsCommunicationComplementDevelopmentDigestive System DisordersDirect CostsDiseaseEffectivenessEnvironmentFacultyFosteringFundingGastrointestinal DiseasesGastrointestinal tract structureGoalsHealthcareHumanImmune responseImmunityIndividualInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInfrastructureInstitutionInvestmentsLaboratory ResearchLinkLiverLiver diseasesMentorsMissionMonoclonal Antibody R24National Institute of Diabetes and Digestive and Kidney DiseasesPatient CarePhenotypePre-Clinical ModelPreventionProductivityResearchResearch PersonnelResearch SupportResourcesRoleScientistSeriesServicesSpecimenSystemTechnologyTranslational ResearchUniversitiesWorkbasecareercost effectivedesignflexibilityfunctional genomicsgastrointestinalhigh riskhost-microbe interactionshuman tissueimprovedinnovationlecturesmedical schoolsmembermicrobiome researchmouse modelnext generationnovelpatient populationpreclinical studyprogramsrepositoryresearch and developmentsymposiumweb site
中文摘要
总结
圣地亚哥消化系统疾病研究中心成立于33个杰出的研究基地,
研究人员目前的消化系统疾病相关资金为15,689,402美元,年度直接费用总额为
其中5,711,412美元(36.4%)来自NIDDK。该中心的总体使命是支持基本的、翻译性的
和临床研究,这将导致改善治疗和预防炎症性疾病的
消化系统该中心的主要目标是为一个国家的研究实验室提供服务。
圣地亚哥地区四个相邻研究机构的联盟,将促进研究生产力,
新的研究方向,并鼓励富有成效的合作。圣地亚哥的另一个主要目标
消化系统疾病研究中心通过试点/可行性研究加强新的消化系统疾病研究
丰富的计划。该中心支持三个相互关联的生物医学研究核心,
旨在提高中心成员的研究潜力和生产力。人类翻译
核心建立在临床和转化研究的现有专业知识基础上,
标本和利用独特的现有库的炎症性肠病和肝病。的
临床前模型核心促进和协助表征和理解胃肠道和肝脏
使用鼠模型。微生物学和功能基因组学核心提供尖端和
在微生物组学和功能基因组学方面以成本效益高的方式获得测序技术。
此外,一个行政核心在行政上支持中心,并协调试点/可行性
丰富的计划。这些核心共同提供高质量和最先进的研究资源
提高成员的协作积极性和有效性,促进青少年的发展
investigators.结合试点/可行性和丰富计划,圣地亚哥消化系统疾病
研究中心将补充一个强大的科学家骨干集中在一系列重要的炎症
胃肠道和肝脏疾病。通过创造一个独特的环境来培养新的研究
想法和互动,圣地亚哥消化疾病研究中心提供了一个独特的机会,
整合临床和实验室研究,以促进对消化系统疾病的基本认识,并提高
这些疾病患者的健康和护理。
英文摘要
Summary
The San Diego Digestive Diseases Research Center is founded on a research base of 33 outstanding
investigators with current digestive diseases-relevant funding of $15,689,402 in total annual direct costs, of
which $5,711,412 (36.4%) are from NIDDK. The overall mission of the Center is to support basic, translational
and clinical research that will lead to improved treatment and prevention of inflammatory diseases of the
digestive system. The primary goal of the Center is to provide services to the research laboratories of a
consortium of four adjacent research institutions in the San Diego area that will foster research productivity and
new research directions, and encourage productive collaborations. Another major goal of the San Diego
Digestive Diseases Research Center is to enhance new digestive diseases research through Pilot/Feasibility
and Enrichment programs. The Center supports three interrelated Biomedical Research Cores that are
designed to enhance the research potential and productivity of the Center members. The Human Translational
Core builds upon existing expertise in clinical and translational research to provide access to human
specimens and leverages unique existing repositories of inflammatory bowel disease and liver diseases. The
Preclinical Models Core facilitates and assists in characterizing and understanding of gastrointestinal and liver
diseases using murine models. The Microbiomics and Functional Genomics Core provides cutting-edge and
cost-effective access to sequencing-based technologies in microbiomics and functional genomics.
Furthermore, an Administrative Core supports the Center administratively and coordinates the Pilot/Feasibility
and Enrichment programs. Together, these Cores provide high-quality and state-of-the-art research resources
to increase collaborative activity and effectiveness of the members, and promote the development of junior
investigators. Combined with the Pilot/Feasibility and Enrichment programs, the San Diego Digestive Diseases
Research Center will complement a strong cadre of scientists focused on a range of important inflammatory
diseases of the gastrointestinal tract and liver. By creating a unique environment to nurture novel research
ideas and interactions, the San Diego Digestive Diseases Research Center presents a unique opportunity to
integrate clinical and bench research to advance the basic understanding of digestive diseases, and enhance
the health and care of patients suffering from those diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Membrane-cloaked nanoparticles as mucosal vaccines against giardiasis
-
批准号:10495210
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2021
-
负责人:LARS ECKMANN
-
依托单位:
Proteasome inhibitors against mucosal protozoan pathogens
-
批准号:10674897
-
项目类别:
-
资助金额:$64.84万
-
财政年份:2021
-
负责人:LARS ECKMANN
-
依托单位:
Proteasome inhibitors against mucosal protozoan pathogens
-
批准号:10367246
-
项目类别:
-
资助金额:$64.84万
-
财政年份:2021
-
负责人:LARS ECKMANN
-
依托单位:
Membrane-cloaked nanoparticles as mucosal vaccines against giardiasis
-
批准号:10351416
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2021
-
负责人:LARS ECKMANN
-
依托单位:
San Diego Digestive Diseases Research Center
-
批准号:10617213
-
项目类别:
-
资助金额:$118.46万
-
财政年份:2019
-
负责人:LARS ECKMANN
-
依托单位:
Selective proteasome inhibitors for trichomoniasis
-
批准号:9806764
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2019
-
负责人:LARS ECKMANN
-
依托单位:
Pilot and Feasibility Program
-
批准号:10395974
-
项目类别:
-
资助金额:$17.64万
-
财政年份:2019
-
负责人:LARS ECKMANN
-
依托单位:
Pilot and Feasibility Program
-
批准号:10617225
-
项目类别:
-
资助金额:$17.64万
-
财政年份:2019
-
负责人:LARS ECKMANN
-
依托单位:
High-potency nitro antimicrobials for topical treatment of trichomoniasis
-
批准号:9049219
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2016
-
负责人:LARS ECKMANN
-
依托单位:
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists
-
批准号:8962082
-
项目类别:
-
资助金额:$63.74万
-
财政年份:2015
-
负责人:LARS ECKMANN
-
依托单位:
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists
-
批准号:9273358
-
项目类别:
-
资助金额:$62.37万
-
财政年份:2015
-
负责人:LARS ECKMANN
-
依托单位:
Mouse Model Core
-
批准号:7757167
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2009
-
负责人:LARS ECKMANN
-
依托单位:
Click chemistry for novel antimicrobials against periodontal pathogens
-
批准号:7933971
-
项目类别:
-
资助金额:$47.62万
-
财政年份:2009
-
负责人:LARS ECKMANN
-
依托单位:
Click chemistry for novel antimicrobials against periodontal pathogens
-
批准号:7819386
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2009
-
负责人:LARS ECKMANN
-
依托单位:
Mucosal Responses to Minimally Invasive Pathogens
-
批准号:7757159
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2009
-
负责人:LARS ECKMANN
-
依托单位:
The UCSD Digestive Diseases Research Development Center
-
批准号:7789482
-
项目类别:
-
资助金额:$54.08万
-
财政年份:2008
-
负责人:LARS ECKMANN
-
依托单位:
The UCSD Digestive Diseases Research Development Center
-
批准号:8053901
-
项目类别:
-
资助金额:$50.21万
-
财政年份:2008
-
负责人:LARS ECKMANN
-
依托单位:
The UCSD Digestive Diseases Research Development Center
-
批准号:8268140
-
项目类别:
-
资助金额:$50.21万
-
财政年份:2008
-
负责人:LARS ECKMANN
-
依托单位:
Next-generation 5-nitroimidazoles against giardiasis
-
批准号:8116019
-
项目类别:
-
资助金额:$103.63万
-
财政年份:2007
-
负责人:LARS ECKMANN
-
依托单位:
Mucosal Responses to Minimally Invasive Pathogens
-
批准号:7509283
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2007
-
负责人:LARS ECKMANN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: